Salud financiera de hoja de balance de Medexus Pharmaceuticals
Salud financiera controles de criterios 3/6
Medexus Pharmaceuticals tiene un patrimonio de accionistas total de $29.6M y una deuda total de $51.7M, lo que sitúa su ratio deuda-patrimonio en 174.9%. Sus activos y pasivos totales son $160.4M y $130.8M respectivamente. El BAIT de Medexus Pharmaceuticals es de $12.8M, por lo que su ratio de cobertura de intereses es de 0.9. Tiene efectivo e inversiones a corto plazo que ascienden a $8.2M.
Información clave
174.9%
Ratio deuda-patrimonio
US$51.70m
Deuda
| Ratio de cobertura de intereses | 0.9x |
| Efectivo | US$8.21m |
| Patrimonio | US$29.56m |
| Total pasivo | US$130.82m |
| Activos totales | US$160.38m |
Actualizaciones recientes sobre salud financiera
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden
Apr 25
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 11Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky
Jan 19Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 22Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?
Dec 16Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Aug 04Recent updates
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden
Apr 25Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive
Mar 03Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story
Jan 06Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors
Oct 11Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 11Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky
Jan 19Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 22Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?
Dec 16Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially
Aug 21Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Aug 04Medexus Pharmaceuticals Inc. (CVE:MDP): When Will It Breakeven?
May 04The Independent Director of Medexus Pharmaceuticals Inc. (CVE:MDP), Michael Mueller, Just Bought 34% More Shares
Feb 26Did Business Growth Power Medexus Pharmaceuticals' (CVE:MDP) Share Price Gain of 174%?
Feb 24Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($74.1M) de MDP superan a sus pasivos a corto plazo ($66.5M).
Pasivo a largo plazo: Los activos a corto plazo de MDP ($74.1M) superan a sus pasivos a largo plazo ($64.3M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de MDP (147.1%) se considera alta.
Reducción de la deuda: MDP's debt to equity ratio has increased from 39% to 174.9% over the past 5 years.
Cobertura de la deuda: La deuda de MDP está bien cubierta por el flujo de caja operativo (40.6%).
Cobertura de intereses: Los pagos de intereses de la deuda de MDP no están bien cubiertos por el BAIT (0.9x cobertura).